PLAK_HUMAN - dbPTM
PLAK_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PLAK_HUMAN
UniProt AC P14923
Protein Name Junction plakoglobin
Gene Name JUP
Organism Homo sapiens (Human).
Sequence Length 745
Subcellular Localization Cell junction, adherens junction . Cell junction, desmosome . Cytoplasm, cytoskeleton . Membrane
Peripheral membrane protein . Cytoplasmic in a soluble and membrane-associated form.
Protein Description Common junctional plaque protein. The membrane-associated plaques are architectural elements in an important strategic position to influence the arrangement and function of both the cytoskeleton and the cells within the tissue. The presence of plakoglobin in both the desmosomes and in the intermediate junctions suggests that it plays a central role in the structure and function of submembranous plaques. Acts as a substrate for VE-PTP and is required by it to stimulate VE-cadherin function in endothelial cells. Can replace beta-catenin in E-cadherin/catenin adhesion complexes which are proposed to couple cadherins to the actin cytoskeleton (By similarity)..
Protein Sequence MEVMNLMEQPIKVTEWQQTYTYDSGIHSGANTCVPSVSSKGIMEEDEACGRQYTLKKTTTYTQGVPPSQGDLEYQMSTTARAKRVREAMCPGVSGEDSSLLLATQVEGQATNLQRLAEPSQLLKSAIVHLINYQDDAELATRALPELTKLLNDEDPVVVTKAAMIVNQLSKKEASRRALMGSPQLVAAVVRTMQNTSDLDTARCTTSILHNLSHHREGLLAIFKSGGIPALVRMLSSPVESVLFYAITTLHNLLLYQEGAKMAVRLADGLQKMVPLLNKNNPKFLAITTDCLQLLAYGNQESKLIILANGGPQALVQIMRNYSYEKLLWTTSRVLKVLSVCPSNKPAIVEAGGMQALGKHLTSNSPRLVQNCLWTLRNLSDVATKQEGLESVLKILVNQLSVDDVNVLTCATGTLSNLTCNNSKNKTLVTQNSGVEALIHAILRAGDKDDITEPAVCALRHLTSRHPEAEMAQNSVRLNYGIPAIVKLLNQPNQWPLVKATIGLIRNLALCPANHAPLQEAAVIPRLVQLLVKAHQDAQRHVAAGTQQPYTDGVRMEEIVEGCTGALHILARDPMNRMEIFRLNTIPLFVQLLYSSVENIQRVAAGVLCELAQDKEAADAIDAEGASAPLMELLHSRNEGTATYAAAVLFRISEDKNPDYRKRVSVELTNSLFKHDPAAWEAAQSMIPINEPYGDDMDATYRPMYSSDVPLDPLEMHMDMDGDYPIDTYSDGLRPPYPTADHMLA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEVMNLME
-------CCCCCCCC
8.7022223895
14PhosphorylationMEQPIKVTEWQQTYT
CCCCEEEEEEEEEEE
26.8921945579
14O-linked_GlycosylationMEQPIKVTEWQQTYT
CCCCEEEEEEEEEEE
26.8928510447
19PhosphorylationKVTEWQQTYTYDSGI
EEEEEEEEEECCCCC
11.6121945579
20PhosphorylationVTEWQQTYTYDSGIH
EEEEEEEEECCCCCC
10.0421945579
21PhosphorylationTEWQQTYTYDSGIHS
EEEEEEEECCCCCCC
25.0021945579
22PhosphorylationEWQQTYTYDSGIHSG
EEEEEEECCCCCCCC
9.5621945579
24PhosphorylationQQTYTYDSGIHSGAN
EEEEECCCCCCCCCC
29.2721945579
28PhosphorylationTYDSGIHSGANTCVP
ECCCCCCCCCCCCCC
37.3721945579
32PhosphorylationGIHSGANTCVPSVSS
CCCCCCCCCCCCCCC
17.8521945579
36PhosphorylationGANTCVPSVSSKGIM
CCCCCCCCCCCCCCC
17.7721945579
38PhosphorylationNTCVPSVSSKGIMEE
CCCCCCCCCCCCCCC
30.5821945579
39PhosphorylationTCVPSVSSKGIMEED
CCCCCCCCCCCCCCH
32.5221945579
40UbiquitinationCVPSVSSKGIMEEDE
CCCCCCCCCCCCCHH
44.9721906983
53PhosphorylationDEACGRQYTLKKTTT
HHHCCCEEEEEEEEE
16.8121945579
54PhosphorylationEACGRQYTLKKTTTY
HHCCCEEEEEEEEEE
24.6221945579
56UbiquitinationCGRQYTLKKTTTYTQ
CCCEEEEEEEEEECC
40.03-
57UbiquitinationGRQYTLKKTTTYTQG
CCEEEEEEEEEECCC
54.97-
58PhosphorylationRQYTLKKTTTYTQGV
CEEEEEEEEEECCCC
23.8421945579
59PhosphorylationQYTLKKTTTYTQGVP
EEEEEEEEEECCCCC
27.0421945579
60PhosphorylationYTLKKTTTYTQGVPP
EEEEEEEEECCCCCC
29.7821945579
61PhosphorylationTLKKTTTYTQGVPPS
EEEEEEEECCCCCCC
8.5821945579
62PhosphorylationLKKTTTYTQGVPPSQ
EEEEEEECCCCCCCC
19.4321945579
68PhosphorylationYTQGVPPSQGDLEYQ
ECCCCCCCCCCCHHH
40.5021945579
74PhosphorylationPSQGDLEYQMSTTAR
CCCCCCHHHHHHHHH
19.4721945579
77PhosphorylationGDLEYQMSTTARAKR
CCCHHHHHHHHHHHH
13.6921945579
78PhosphorylationDLEYQMSTTARAKRV
CCHHHHHHHHHHHHH
21.0921945579
79PhosphorylationLEYQMSTTARAKRVR
CHHHHHHHHHHHHHH
13.5721945579
94PhosphorylationEAMCPGVSGEDSSLL
HHHCCCCCCCCCHHE
42.2428555341
98PhosphorylationPGVSGEDSSLLLATQ
CCCCCCCCHHEEEEE
20.7026657352
99PhosphorylationGVSGEDSSLLLATQV
CCCCCCCHHEEEEEE
35.0428857561
104PhosphorylationDSSLLLATQVEGQAT
CCHHEEEEEEECCCC
32.8728857561
120PhosphorylationLQRLAEPSQLLKSAI
HHHHHCHHHHHHHHH
25.6020068231
124UbiquitinationAEPSQLLKSAIVHLI
HCHHHHHHHHHHHHH
46.5721906983
125PhosphorylationEPSQLLKSAIVHLIN
CHHHHHHHHHHHHHC
24.1728152594
133PhosphorylationAIVHLINYQDDAELA
HHHHHHCCCCHHHHH
13.3128152594
141PhosphorylationQDDAELATRALPELT
CCHHHHHHHHHHHHH
29.1522817900
149UbiquitinationRALPELTKLLNDEDP
HHHHHHHHHCCCCCC
64.7021906983
160PhosphorylationDEDPVVVTKAAMIVN
CCCCHHHHHHHHHHH
11.89-
161UbiquitinationEDPVVVTKAAMIVNQ
CCCHHHHHHHHHHHH
23.6521906983
170PhosphorylationAMIVNQLSKKEASRR
HHHHHHHCHHHHHHH
31.7320860994
171UbiquitinationMIVNQLSKKEASRRA
HHHHHHCHHHHHHHH
64.32-
175PhosphorylationQLSKKEASRRALMGS
HHCHHHHHHHHHCCC
24.3229514088
182PhosphorylationSRRALMGSPQLVAAV
HHHHHCCCHHHHHHH
8.7726846344
193SulfoxidationVAAVVRTMQNTSDLD
HHHHHHHHCCCCCCH
1.7128183972
196PhosphorylationVVRTMQNTSDLDTAR
HHHHHCCCCCCHHHH
13.5128258704
197PhosphorylationVRTMQNTSDLDTARC
HHHHCCCCCCHHHHH
43.6627251275
201PhosphorylationQNTSDLDTARCTTSI
CCCCCCHHHHHHHHH
24.2528258704
224UbiquitinationEGLLAIFKSGGIPAL
CCHHHHHHCCCHHHH
41.9221906983
272UbiquitinationRLADGLQKMVPLLNK
HHHHHHHHHHHHHCC
47.08-
279UbiquitinationKMVPLLNKNNPKFLA
HHHHHHCCCCCCEEE
59.06-
322PhosphorylationLVQIMRNYSYEKLLW
HHHHHHHCCHHHHHH
11.4129978859
323PhosphorylationVQIMRNYSYEKLLWT
HHHHHHCCHHHHHHH
30.3029978859
324PhosphorylationQIMRNYSYEKLLWTT
HHHHHCCHHHHHHHH
13.5129978859
326UbiquitinationMRNYSYEKLLWTTSR
HHHCCHHHHHHHHHH
40.42-
326AcetylationMRNYSYEKLLWTTSR
HHHCCHHHHHHHHHH
40.4225825284
336AcetylationWTTSRVLKVLSVCPS
HHHHHHHHHHHCCCC
37.9726051181
336UbiquitinationWTTSRVLKVLSVCPS
HHHHHHHHHHHCCCC
37.97-
345UbiquitinationLSVCPSNKPAIVEAG
HHCCCCCCCEEEEEC
39.91-
359UbiquitinationGGMQALGKHLTSNSP
CHHHHHHHHHCCCCH
35.97-
385UbiquitinationNLSDVATKQEGLESV
HHHHHCHHHHHHHHH
36.2921906983
401PhosphorylationKILVNQLSVDDVNVL
HHHHHCCCCCCEEEE
17.4623090842
409PhosphorylationVDDVNVLTCATGTLS
CCCEEEEEECCCCHH
8.8723090842
412PhosphorylationVNVLTCATGTLSNLT
EEEEEECCCCHHCCE
32.6123090842
414PhosphorylationVLTCATGTLSNLTCN
EEEECCCCHHCCEEC
23.7423090842
424UbiquitinationNLTCNNSKNKTLVTQ
CCEECCCCCCEEEEC
65.67-
426UbiquitinationTCNNSKNKTLVTQNS
EECCCCCCEEEECCH
47.15-
427PhosphorylationCNNSKNKTLVTQNSG
ECCCCCCEEEECCHH
35.5425867546
430PhosphorylationSKNKTLVTQNSGVEA
CCCCEEEECCHHHHH
25.7522817900
433PhosphorylationKTLVTQNSGVEALIH
CEEEECCHHHHHHHH
34.1025867546
448AcetylationAILRAGDKDDITEPA
HHHHCCCCCCCCHHH
57.2826051181
448UbiquitinationAILRAGDKDDITEPA
HHHHCCCCCCCCHHH
57.28-
452PhosphorylationAGDKDDITEPAVCAL
CCCCCCCCHHHHHHH
42.8022210691
463PhosphorylationVCALRHLTSRHPEAE
HHHHHHHHHCCCHHH
20.0022817900
475PhosphorylationEAEMAQNSVRLNYGI
HHHHHHHHHHHHCCH
9.1322210691
480PhosphorylationQNSVRLNYGIPAIVK
HHHHHHHCCHHHHHH
22.4827273156
499UbiquitinationPNQWPLVKATIGLIR
CCCCHHHHHHHHHHH
47.7121906983
533UbiquitinationRLVQLLVKAHQDAQR
HHHHHHHHHCHHHHH
39.87-
546PhosphorylationQRHVAAGTQQPYTDG
HHHHHCCCCCCCCCC
21.2121945579
550PhosphorylationAAGTQQPYTDGVRME
HCCCCCCCCCCCCHH
17.0821945579
551PhosphorylationAGTQQPYTDGVRMEE
CCCCCCCCCCCCHHH
32.7221945579
564PhosphorylationEEIVEGCTGALHILA
HHHHCHHCCHHHHHH
36.0220068231
595PhosphorylationLFVQLLYSSVENIQR
HHHHHHHHCHHHHHH
28.0724719451
596PhosphorylationFVQLLYSSVENIQRV
HHHHHHHCHHHHHHH
21.6422817900
641PhosphorylationLHSRNEGTATYAAAV
HHHCCCCHHHHHHHH
15.0621945579
643PhosphorylationSRNEGTATYAAAVLF
HCCCCHHHHHHHHHH
17.3321945579
644PhosphorylationRNEGTATYAAAVLFR
CCCCHHHHHHHHHHH
7.5621945579
660PhosphorylationSEDKNPDYRKRVSVE
HCCCCCCHHHHHHHH
21.2025394399
664PhosphorylationNPDYRKRVSVELTNS
CCCHHHHHHHHHHHH
9.3717081983
665PhosphorylationPDYRKRVSVELTNSL
CCHHHHHHHHHHHHH
17.5722167270
669PhosphorylationKRVSVELTNSLFKHD
HHHHHHHHHHHHHCC
14.8422167270
671PhosphorylationVSVELTNSLFKHDPA
HHHHHHHHHHHCCHH
29.9223927012
701PhosphorylationGDDMDATYRPMYSSD
CCCCCCCCCCCCCCC
17.9122817900
724PhosphorylationHMDMDGDYPIDTYSD
CCCCCCCCCCCCCCC
13.9722817900
728PhosphorylationDGDYPIDTYSDGLRP
CCCCCCCCCCCCCCC
26.1624275569
729PhosphorylationGDYPIDTYSDGLRPP
CCCCCCCCCCCCCCC
10.8722817900
730PhosphorylationDYPIDTYSDGLRPPY
CCCCCCCCCCCCCCC
27.5610902626

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
133YPhosphorylationKinaseFYNP06241
PSP
550YPhosphorylationKinaseFERP16591
PSP
550YPhosphorylationKinaseFYNP06241
PSP
644YPhosphorylationKinaseSRCP12931
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PLAK_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PLAK_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NTAQ1_HUMANWDYHV1physical
16189514
RIBC2_HUMANRIBC2physical
16189514
IKBE_HUMANNFKBIEphysical
16189514
CNBP1_HUMANCTNNBIP1physical
16189514
CTNA1_HUMANCTNNA1physical
9762469
APC_HUMANAPCphysical
8074697
CADH1_HUMANCDH1physical
8074697
ERBB2_HUMANERBB2physical
7702605
DESP_HUMANDSPphysical
9348293
DSG2_HUMANDSG2physical
10769205
DSG2_HUMANDSG2physical
8749329
CTNA1_HUMANCTNNA1physical
9110993
CADH1_MOUSECdh1physical
12847106
DSC1_MOUSEDsc1physical
12847106
DSG1A_MOUSEDsg1aphysical
12847106
DSC1_HUMANDSC1physical
14673151
PLEC_HUMANPLECphysical
22939629
PTH2_HUMANPTRH2physical
22939629
RL21_HUMANRPL21physical
22939629
S2544_HUMANSLC25A44physical
22939629
SYIM_HUMANIARS2physical
22939629
CC130_HUMANCCDC130physical
22365833
CTNA3_HUMANCTNNA3physical
23718855
NFAC4_HUMANNFATC4physical
21988832
CTNA1_HUMANCTNNA1physical
25241761
APC_HUMANAPCphysical
25241761
ERBB2_HUMANERBB2physical
25241761
CTNB1_HUMANCTNNB1physical
25241761

Drug and Disease Associations
Kegg Disease
H00293 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
H00669 Naxos disease and Carvajal syndrome
OMIM Disease
601214Naxos disease (NXD)
611528Arrhythmogenic right ventricular dysplasia, familial, 12 (ARVD12)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PLAK_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182 AND SER-665, ANDMASS SPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-660, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-660, AND MASSSPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY.

TOP